Search results for: Value-Based Pricing
Filter search results
The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision
8 October 2020
…– value that extends well beyond preserving the health of the vaccinated individual and avoiding the costs associated with COVID-19 disease. These broader value aspects are by no means unique…
OHE Lunchtime Seminar: How Do We Measure the ‘Value’ in Value-based Care?
19 August 2019
…‘How Do We Measure the ‘Value’ in Value-based Care?’. To be held on 17 September 2019 from 12 p.m. to 2 p.m. Value-based care differs from a fee-for-service approach, in…
Multi-indication Pricing: Pros, Cons and Applicability to the UK
1 October 2015
…medicines are to reflect their value, then multi-indication medicines should have different prices across major indication, reflecting different values. Multi-indication pricing (MIP) involves setting a different price for each major…
Virtual ISPOR European 2020
10 November 2020
…post questions to panellists in a live Q&A session Value-Based Pricing and Market Allocative Efficiency: How Should Cost-Effectiveness Thresholds be Set to “Optimally” Distribute Value between Payers and Developers? – available to…
The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK
1 July 2019
…to assess the life-cycle value of innovative medicines based on the example of Second-Generation Antipsychotics (SGA). Assessing the entire life-cycle of SGA, the study explores how much additional value has…
New Research: Achieving Efficient Prices for Drugs in a Global Context
7 February 2013
…in countries with universal insurance may approximate a value-based differential pricing model if willingness to pay is used appropriately in setting a cost-effectiveness threshold for pricing and reimbursement decisions. If…
Differential Pricing – A Win-Win Solution?
2 March 2011
Summarised in this post is a just-released OHE Occasional Paper that examines the potentially positive impact of differential pricing in Europe and the overall negative effects of international reference pricing…
European Union Pharmaceutical Markets: A Case for Differential Pricing?
11 August 2015
…blocks. Third, a differential pricing option requiring minimum EU centralisation would be possible, but only if discounts and/or the terms of voluntary contractual agreements were confidential. Implementing differential pricing under…
The case for adopting a broader perspective on value in Health Technology Assessment
3 March 2026
…to invest in the collection of such data until HTA bodies confirm their willingness to adopt a broader perspective in their appraisals. Incorporating broader value elements will increase value-based prices…